1. Home
  2. FLO vs TNDM Comparison

FLO vs TNDM Comparison

Compare FLO & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flowers Foods Inc.

FLO

Flowers Foods Inc.

N/A

Current Price

$6.43

Market Cap

1.2B

ML Signal

N/A

Logo Tandem Diabetes Care Inc.

TNDM

Tandem Diabetes Care Inc.

N/A

Current Price

$17.97

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FLO
TNDM
Founded
1919
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Medical/Dental Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2000
2013

Fundamental Metrics

Financial Performance
Metric
FLO
TNDM
Price
$6.43
$17.97
Analyst Decision
Hold
Buy
Analyst Count
5
25
Target Price
$7.30
★ $27.38
AVG Volume (30 Days)
★ 5.5M
2.3M
Earning Date
11-12-2026
11-05-2026
Dividend Yield
★ 7.45%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.39
N/A
Revenue
★ $5,256,479,000.00
$1,014,736,000.00
Revenue This Year
N/A
$5.85
Revenue Next Year
N/A
$10.72
P/E Ratio
$17.24
★ N/A
Revenue Growth
3.00
★ 7.93
52 Week Low
$5.40
$12.26
52 Week High
$12.09
$29.65

Technical Indicators

Market Signals
Indicator
FLO
TNDM
Relative Strength Index (RSI) 51.79 50.60
Support Level $5.74 $17.61
Resistance Level $6.44 $18.13
Average True Range (ATR) 0.30 1.23
MACD 0.06 -0.04
Stochastic Oscillator 45.07 50.52

Price Performance

Historical Comparison
FLO
TNDM

About FLO Flowers Foods Inc.

Flowers Foods Inc operates as a producer and marketer of packaged bakery foods in the United States. Its principal products include breads, buns, rolls, snack items (bars, cakes, cookies, and crackers), bagels, English muffins, tortillas, and baking mixes. These products are sold under the brand names Nature's Own, Dave's Killer Bread (DKB), Canyon Bakehouse, Simple Mills, Wonder, and Tastykake. The company derives the majority of its revenue from the sales of its bakery products.

About TNDM Tandem Diabetes Care Inc.

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on the Sigi tubeless patch pump. Tandem is also developing a fully closed-loop algorithm for its pumps. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 3 to 7 days.

Share on Social Networks: